Dr. Modupe Idowu, MD
Claim this profileUniversity of Texas Health Science Center at Houston
Studies Sickle Cell Disease and Thalassemia
Studies Sickle Cell Disease
10 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Modupe Idowu, MD is currently running
Red Blood Cell Exchange
for Sickle Cell Disease
The SCD-CARRE trial is a Phase 3, prospective, randomized, multicenter, controlled, parallel two-arm study aimed to determine if automated exchange blood transfusion and standard of care administered to high mortality risk adult SCD patients reduces the total number of episodes of clinical worsening of SCD requiring acute health care encounters (non-elective infusion center/ER/hospital visits) or resulting in death over 12 months as compared with standard of care.
Recruiting2 awards Phase 312 criteria
GSK4172239D
for Sickle Cell Anemia
This trial is testing a new drug called GSK4172239D in people with sickle cell disease. The drug changes into an active form inside the body to help treat the condition. The study aims to see if the drug is safe and how it behaves in the body.
Recruiting0 awards Phase 1
More about Modupe Idowu, MD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Modupe Idowu, MD has experience with
- Crizanlizumab
- AG-946
- GBT021601
- Automated Exchange Blood Transfusion
- Standard Of Care
- Voxelotor
Breakdown of trials Modupe Idowu, MD has run
Sickle Cell Disease and Thalassemia
Sickle Cell Disease
Sickle Cell Anemia
Healthy Subjects
Sickle cell crisis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Modupe Idowu, MD specialize in?
Modupe Idowu, MD focuses on Sickle Cell Disease and Thalassemia and Sickle Cell Disease. In particular, much of their work with Sickle Cell Disease and Thalassemia has involved treating patients, or patients who are undergoing treatment.
Is Modupe Idowu, MD currently recruiting for clinical trials?
Yes, Modupe Idowu, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Modupe Idowu, MD has studied deeply?
Yes, Modupe Idowu, MD has studied treatments such as Crizanlizumab, AG-946, GBT021601.
What is the best way to schedule an appointment with Modupe Idowu, MD?
Apply for one of the trials that Modupe Idowu, MD is conducting.
What is the office address of Modupe Idowu, MD?
The office of Modupe Idowu, MD is located at: University of Texas Health Science Center at Houston, Houston, Texas 77030 United States. This is the address for their practice at the University of Texas Health Science Center at Houston.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.